Jeil Pharma Holdings, 24.75% Rise Amid COVID-19 (Nafamostat) Theme Uptrend

On the 10th, the COVID-19 (Nafamostat) theme showed strength, rising 3.30% compared to the previous day, while Jeil Pharma Holdings, a related stock attracting attention, surged 24.75% compared to the previous day. Jeil Pharma Holdings is known to have converted into a holding company in June 2017.

[Graph] Major stock price changes in the COVID-19 (Nafamostat) theme

According to provisional data compiled at 15:59, foreigners are net selling 1,000 shares of Jeil Pharma Holdings.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Jeil Pharma Holdings’ quant financial score is 23.5 points, ranking 6th within the COVID-19 (Nafamostat) theme due to higher growth and stability scores compared to the average of other related stocks. This indicates that Jeil Pharma Holdings has a relatively fast growth rate in sales and net profit compared to other stocks in the theme, and also demonstrates good responsiveness to changes in domestic and international economic environments.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.